FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

11d ago

PremiumPress Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity

16d ago

PremiumPress Releases

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer

17d ago

PremiumPress Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

1M ago

More RHHBY News >

RHHBY News on the Web

2024-05-31

Novartis (NVS) Reports Positive Long-Term Data on CSU Drug

Zacks

Neutral

2024-05-31

Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More

Zacks

Neutral

2024-05-29

Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag

Zacks

Neutral

2024-05-29

FDA Grants Priority Review To Genentech's Inavolisib For Advanced HR+, HER2- Breast Cancer Mutation

rttnews

Neutral

2024-05-29

FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

Yahoo Finance

Neutral

2024-05-29

FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

Yahoo Finance

Neutral

2024-05-27

Hitachi High-Tech, Roche Extend Partnership

rttnews

Neutral

2024-05-27

Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

RHHBY

Sector Average

Media Buzz

This Week8 articles

Weekly Average8.75 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RHHBY’s Media Buzz Sentiment?

8 articles about RHHBY were published this week. In an average week, 8.75 articles are published.

What is RHHBY’s weekly average amount of articles?

In an average week, 8.75 articles about RHHBY are published.

What is RHHBY’s News Sentiment?

50% of articles about RHHBY were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

LNTHLantheus

50JKangji Medical Holdings Limited

INSMInsmed

CORTCorcept Therapeutics

PG3Probiotec Limited

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing